138 related articles for article (PubMed ID: 11494233)
81. Immunohistochemistry and microsatellite instability testing for selecting MLH1, MSH2 and MSH6 mutation carriers in hereditary non-polyposis colorectal cancer.
Caldés T; Godino J; Sanchez A; Corbacho C; De la Hoya M; Lopez Asenjo J; Saez C; Sanz J; Benito M; Ramon Y Cajal S; Diaz-Rubio E
Oncol Rep; 2004 Sep; 12(3):621-9. PubMed ID: 15289847
[TBL] [Abstract][Full Text] [Related]
82. Comparison of selection strategies for genetic testing of patients with hereditary nonpolyposis colorectal carcinoma: effectiveness and cost-effectiveness.
Reyes CM; Allen BA; Terdiman JP; Wilson LS
Cancer; 2002 Nov; 95(9):1848-56. PubMed ID: 12404277
[TBL] [Abstract][Full Text] [Related]
83. MSH2 mutation carriers are at higher risk of cancer than MLH1 mutation carriers: a study of hereditary nonpolyposis colorectal cancer families.
Vasen HF; Stormorken A; Menko FH; Nagengast FM; Kleibeuker JH; Griffioen G; Taal BG; Moller P; Wijnen JT
J Clin Oncol; 2001 Oct; 19(20):4074-80. PubMed ID: 11600610
[TBL] [Abstract][Full Text] [Related]
84. Detection of mutations in mismatch repair genes in Portuguese families with hereditary non-polyposis colorectal cancer (HNPCC) by a multi-method approach.
Fidalgo P; Almeida MR; West S; Gaspar C; Maia L; Wijnen J; Albuquerque C; Curtis A; Cravo M; Fodde R; Leitao CN; Burn J
Eur J Hum Genet; 2000 Jan; 8(1):49-53. PubMed ID: 10713887
[TBL] [Abstract][Full Text] [Related]
85. Comparison of Alu-PCR, microsatelite instability, and immunohistochemical analyses in finding features characteristic for hereditary nonpolyposis colorectal cancer.
Debniak T; Gorski B; Cybulski C; Jakubowska A; Kurzawski G; Kladny J; Lubinski J
J Cancer Res Clin Oncol; 2001 Sep; 127(9):565-9. PubMed ID: 11570578
[TBL] [Abstract][Full Text] [Related]
86. Distinct clinical features associated with microsatellite instability in colorectal cancers of young patients.
Ho JW; Yuen ST; Chung LP; Kwan KY; Chan TL; Leung SY; Chan AS; Tse Cw; Lam PW; Luk IS
Int J Cancer; 2000 Jul; 89(4):356-60. PubMed ID: 10956410
[TBL] [Abstract][Full Text] [Related]
87. [Molecular cancer disposition diagnosis exemplified by colorectal carcinoma. What is the contribution of pathology?].
Rüschoff J; Dietmaier W; Bocker T; Wallinger S; Kullmann F; Beham A; Hofstädter F
Pathologe; 1998 Jul; 19(4):269-78. PubMed ID: 9746911
[TBL] [Abstract][Full Text] [Related]
88. Cystic sebaceous tumors as marker lesions for the Muir-Torre syndrome: a histopathologic and molecular genetic study.
Rütten A; Burgdorf W; Hügel H; Kutzner H; Hosseiny-Malayeri HR; Friedl W; Propping P; Kruse R
Am J Dermatopathol; 1999 Oct; 21(5):405-13. PubMed ID: 10535567
[TBL] [Abstract][Full Text] [Related]
89. Microsatellite analysis of hereditary nonpolyposis colorectal cancer-associated colorectal adenomas by laser-assisted microdissection: correlation with mismatch repair protein expression provides new insights in early steps of tumorigenesis.
Giuffrè G; Müller A; Brodegger T; Bocker-Edmonston T; Gebert J; Kloor M; Dietmaier W; Kullmann F; Büttner R; Tuccari G; Rüschoff J;
J Mol Diagn; 2005 May; 7(2):160-70. PubMed ID: 15858139
[TBL] [Abstract][Full Text] [Related]
90. hMRE11 deficiency leads to microsatellite instability and defective DNA mismatch repair.
Vo AT; Zhu F; Wu X; Yuan F; Gao Y; Gu L; Li GM; Lee TH; Her C
EMBO Rep; 2005 May; 6(5):438-44. PubMed ID: 15864295
[TBL] [Abstract][Full Text] [Related]
91. [Colorectal carcinoma in consideration of the new German S3 guideline 2013].
Neumann JH; Kirchner T
Pathologe; 2014 Nov; 35(6):615-21; quiz 622-3. PubMed ID: 25106124
[TBL] [Abstract][Full Text] [Related]
92. Finnish mutations in Swedish HNPCC families.
Tannergård P; Nordenskjöld M; Lindblom A
Nat Med; 1995 Nov; 1(11):1104. PubMed ID: 7584969
[No Abstract] [Full Text] [Related]
93. Very low incidence of microsatellite instability in rectal cancers from families at risk for HNPCC.
Hoogerbrugge N; Willems R; Van Krieken HJ; Kiemeney LA; Weijmans M; Nagengast FM; Arts N; Brunner HG; Ligtenberg MJ
Clin Genet; 2003 Jan; 63(1):64-70. PubMed ID: 12519374
[TBL] [Abstract][Full Text] [Related]
94. An appendix carcinoid tumor in a patient with hereditary nonpolyposis colorectal cancer.
Miquel C; Sabourin JC; Elias D; Grandjouan S; Viguier J; Ducreux M; Duvillard P; Praz F
Hum Pathol; 2004 Dec; 35(12):1564-7. PubMed ID: 15619218
[TBL] [Abstract][Full Text] [Related]
95. [Glioblastoma multiforme as a manifestation of Turcot syndrome].
Grips E; Wentzensen N; Sutter C; Sedlaczek O; Gebert J; Weigel R; Schwartz A; von Knebel-Doeberitz M; Hennerici M
Nervenarzt; 2002 Feb; 73(2):177-82. PubMed ID: 11975096
[TBL] [Abstract][Full Text] [Related]
96. Chromoendoscopic colonoscopy for detecting preneoplastic lesions in hereditary nonpolyposis colorectal cancer syndrome.
Lecomte T; Cellier C; Meatchi T; Barbier JP; Cugnenc PH; Jian R; Laurent-Puig P; Landi B
Clin Gastroenterol Hepatol; 2005 Sep; 3(9):897-902. PubMed ID: 16234028
[TBL] [Abstract][Full Text] [Related]
97. Microsatellite instability in sporadic-colon-cancer patients with and without liver metastases.
Chen WS; Chen JY; Liu JM; Lin WC; King KL; Whang-Peng J; Yang WK
Int J Cancer; 1997 Aug; 74(4):470-4. PubMed ID: 9291442
[TBL] [Abstract][Full Text] [Related]
98. [Genetic abnormality of hereditary nonpolyposis colorectal cancer and implication of clinical application].
Baba S
Nihon Shokakibyo Gakkai Zasshi; 2000 Aug; 97(8):1017-24. PubMed ID: 10965759
[No Abstract] [Full Text] [Related]
99. DNA mismatch repair status may influence anti-neoplastic effects of butyrate.
Coxhead JM; Williams EA; Mathers JC
Biochem Soc Trans; 2005 Aug; 33(Pt 4):728-9. PubMed ID: 16042586
[TBL] [Abstract][Full Text] [Related]
100. [Metachronous bilateral ureteral cancer in patient with hereditaly nonpolyposis colorectal cancer].
Yamamoto M; Kashiwai H; Hirata N; Matsuki H; Shimizu K; Tanaka N; Ozono S
Nihon Hinyokika Gakkai Zasshi; 2004 Jan; 95(1):63-6. PubMed ID: 14978944
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
